Citius Pharmaceuticals Inc (CTXR)

$CTXR 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.

CEO

Myron Holubiak

Exchange

NASDAQ

Website

www.citiuspharma.com

$M

Total Revenue

10

Employees

$177M

Market Capitalization

-7.70

Price/Earning ratio

Industry Peers

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 19327 2239 2.87 15.52 43.40
Organon & Co. OGN 8644 7891 -4.46 4.95 22.06
Arvinas Inc ARVN 4342 21 8.14 -26.29 -782.93
Tilray Inc TLRY 3286 513 1.23 -9.74 -71.61
ATAI Life Sciences N.V. ATAI 2545 20 5.35 -11.65 -932.88
Cronos Group Inc CRON 2114 57 1.33 -14.64 -258.59
Usana Health Sciences Inc USNA 1837 1254 4.18 13.23 11.09
Phathom Pharmaceuticals Inc PHAT 1178 7.99 -7.35 None
Fulcrum Therapeutics Inc FULC 925 15 11.21 -12.53 -481.07
Intersect ENT Inc XENT 899 103 21.80 -13.10 -66.55
Phibro Animal Health Corp. PAHC 888 833 3.68 16.16 6.53
Edgewise Therapeutics Inc EWTX 848 2.87 -31.45 None
Pliant Therapeutics Inc PLRX 657 13 2.69 -7.66 -613.56
Cyteir Therapeutics Inc CYT 637 3.42 -22.04 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 467 10 2.52 -8.53 -551.28
Chromadex Corp CDXC 433 62 10.92 -18.30 -37.51
Rain Therapeutics Inc RAIN 404 413 2.50 -13.27 123.20
Provention Bio Inc PRVB 400 2.68 -3.12 None
Evolus Inc EOLS 321 77 4.24 -2.15 -171.53
Verrica Pharmaceuticals Inc VRCA 316 12 6.41 -8.69 -301.45
Terns Pharmaceuticals Inc TERN 263 1.46 -7.62 None
Adicet Bio Inc ACET 230 9 1.00 -4.09 -603.06
Milestone Pharmaceuticals Inc MIST 222 15 1.25 -7.50 -215.93
Kaleido Biosciences Inc KLDO 222 1 4.94 -2.49 None
LifeMD Inc LFMD 201 64 -28.62 -1.44 -133.55
Kala Pharmaceuticals Inc KALA 187 11 2.42 -1.48 None
Osmotica Pharmaceuticals Plc OSMT 181 190 2.64 -1.95 -47.85
Citius Pharmaceuticals Inc CTXR 177 2.21 -7.70 None
scPharmaceuticals Inc SCPH 162 119 2.38 -5.36 -27.05
Aquestive Therapeutics Inc AQST 146 42 -3.02 -2.27 -152.73
Eton Pharmaceuticals Inc ETON 123 15 6.11 -10.06 -74.52
Odonate Therapeutics Inc ODT 117 1.47 -1.00 None
Eyenovia Inc EYEN 113 6 12.86 -5.77 -324.94
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Opiant Pharmaceuticals Inc OPNT 90 37 2.71 -86.08 -3.06
Natural Alternatives Internati NAII 89 169 1.26 10.07 5.68
VYNE Therapeutics Inc VYNE 72 16 1.08 3.27 -554.66
India Globalization Capital In IGC 67 0 2.39 -7.65 -981.18
Mannatech Inc MTEX 66 158 2.63 10.35 4.22
Acasti Pharma Inc ACST 42 0 1.81 -2.11 -611.47
Shineco Inc TYHT 36 14 1.85 -1.78 -159.60
Assertio Holdings Inc ASRT 33 117 0.45 -0.58 -38.05
Reviva Pharmaceuticals Holding RVPH 30 1.64 -4.74 None
Baudax Bio Inc BXRX 28 1 -11.98 0.84 None
Nabriva Therapeutics Plc NBRV 28 12 0.83 -0.47 -452.55
Bio-Path Holdings Inc BPTH 28 0 1.29 -2.68 18.96
Timber Pharmaceuticals Inc TMBR 26 0 11.39 0.88 -527.55
Trevi Therapeutics Inc TRVI 26 1.67 -0.74 None
Lexaria Bioscience Corp LEXX 25 1 3.49 -6.45 -445.15
Hoth Therapeutics Inc HOTH 22 1.85 -2.29 None
Cyanotech Corp. CYAN 17 34 0.99 13.57 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.13 -2.04 -31.96

The Metrics That Matter Right Now About Citius Pharmaceuticals Inc. (NASDAQ: CTXR)

19h ago, source: stocksregister

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) price on Thursday, September 16, rose 2.46% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.08. A look at the ...

Should You Expect A Quick Recovery From Citius Pharmaceuticals Inc. (NASDAQ: CTXR) After -124.63% Decline From High?

1d ago, source: marketingsentinel

Citius Pharmaceuticals Inc. (NASDAQ:CTXR)’s traded shares stood at 1.95 million during the last session, with the company’s ...

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Is Becoming An Interest-Losing Stock With A -0.95% Decline

4d ago, source: marketingsentinel

In the last trading session, 3.04 million Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares changed hands as the company’s ...

Citius Pharmaceuticals Inc. (CTXR) is on the roll with an average volume of 8.40M in the recent 3 months

10d ago, source: investchronicle

Let’s start up with the current stock price of Citius Pharmaceuticals Inc. (CTXR), which is $2.18 to be very precise. The Stock rose vividly during the last session to $2.118 after opening rate of $2.

Looking Closely at the Growth Curve for Citius Pharmaceuticals Inc. (CTXR)

9d ago, source: newsheater

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) went up by 0.95% from its latest closing price compared to the recent 1-year high of $4.56. The company’s stock price has collected -6.61% of loss in the last ...

A Look At The Behavior Of Citius Pharmaceuticals Inc. (CTXR) Stock

7d ago, source: stocksregister

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) concluded the trading at $2.10 on Thursday, September 09, with a rise of 1.45% from its closing price on previous day. Taking a look at stock we notice that ...

Citius Pharmaceuticals, a late-stage biopharmaceutical company (PRNewsfoto/Citius Pharmaceuticals, Inc.)

9d ago, source: WFMZ-TV

Citius Pharmaceuticals, a late-stage biopharmaceutical company (PRNewsfoto/) ...

Citius (CTXR) Acquires Dr. Reddy's License for NHL Therapy

9d ago, source: YAHOO!Finance

Citius Pharmaceuticals (CTXR) acquires Dr. Reddy's exclusive license rights for E7777 to treat a rare form of NHL and other ...

Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential

7d ago, source: Business Insider

Disclaimer | Accessibility Statement | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Citius Pharmaceuticals, ...

Citius Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

9d ago, source: Yahoo

8, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class ...

Citius Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

9d ago, source: WFMZ-TV

About Citius Pharmaceuticals, Inc. Citius is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on ...

Your Portfolio